Timo Piironen

Timo Piironen is a seasoned scientist with extensive experience in biotechnology and immune technology. He currently serves as scientific director at Synexa Life Sciences and holds an Adjunct Professor position at the University of Turku. His career spans over two decades, with notable roles including co-founding and leading Syrinx Bioanalytics (acquired
by Synexa in 2022) as Scientific Director and working as a Senior Scientist at Orion Pharma and Bayer HealthCare. Timo earned his PhD in Biotechnology from the University of Turku, where he continues to contribute to academic and industry advancements.